{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:24:22Z","timestamp":1792783462352,"version":"4.5.0"},"reference-count":111,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"NSF Directorate for Engineering","award":["1404008"],"award-info":[{"award-number":["1404008"]}],"id":[{"id":"https:\/\/ror.org\/00b6sbb32","id-type":"ROR","asserted-by":"crossref"}]},{"name":"NSF Directorate for Engineering","award":["2129088"],"award-info":[{"award-number":["2129088"]}],"id":[{"id":"https:\/\/ror.org\/00b6sbb32","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["18PRE33960074"],"award-info":[{"award-number":["18PRE33960074"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["25DIVSUP1478725"],"award-info":[{"award-number":["25DIVSUP1478725"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000861","name":"Burroughs Wellcome Fund","doi-asserted-by":"publisher","award":["Burroughs Wellcome Fund Physician Scientist Institutional Award to the Texas A&M University Academy of Physician Scientists"],"award-info":[{"award-number":["Burroughs Wellcome Fund Physician Scientist Institutional Award to the Texas A&M University Academy of Physician Scientists"]}],"id":[{"id":"10.13039\/100000861","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["T32HL170967"],"award-info":[{"award-number":["T32HL170967"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Eng Tech"],"DOI":"10.1007\/s13239-026-00859-5","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T15:29:39Z","timestamp":1789658979000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cardiovascular Disease and Androgens: Clinical Trends, Potential Mechanisms, and Considerations for Engineering Solutions"],"prefix":"10.1007","author":[{"given":"Madeline N.","family":"Monroe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander L.","family":"Curylo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farshad","family":"Amirkhosravi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric I.","family":"Garcia Huitron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0668-1905","authenticated-orcid":false,"given":"George I.","family":"Ezeokeke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inioluwa G.","family":"Ojediran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1421-4969","authenticated-orcid":false,"given":"Jessica K.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sawyer E.","family":"Cremer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1533-3767","authenticated-orcid":false,"given":"K. Jane","family":"Grande-Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,17]]},"reference":[{"key":"859_CR1","doi-asserted-by":"crossref","unstructured":"Yeap BB, Testosterone C. Testosterone: From Basic to Clinical Aspects. In: Hohl A, editor.: Springer International Publishing; 2017. p. 299-318.","DOI":"10.1007\/978-3-319-46086-4_16"},{"issue":"1","key":"859_CR2","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1161\/ATVBAHA.113.301936","volume":"34","author":"LR Balaoing","year":"2014","unstructured":"Balaoing, L. R., A. D. Post, H. Liu, K. T. Minn, and K. J. Grande-Allen. Age-related changes in aortic valve hemostatic protein regulation. Arterioscler Thromb Vasc Biol. 34(1):72\u201380, 2014.","journal-title":"Arterioscler Thromb Vasc Biol."},{"issue":"1","key":"859_CR3","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s10554-015-0752-5","volume":"32","author":"L Liyanage","year":"2016","unstructured":"Liyanage, L., N. J. Lee, and T. Cook. The impact of gender on cardiovascular system calcification in very elderly patients with severe aortic stenosis. Int J Cardiovasc Imaging. 32(1):173\u2013179, 2016.","journal-title":"Int J Cardiovasc Imaging."},{"issue":"5","key":"859_CR4","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1210\/er.2018-00020","volume":"39","author":"DJ Handelsman","year":"2018","unstructured":"Handelsman, D. J., A. L. Hirschberg, and S. Bermon. Circulating testosterone as the hormonal basis of sex differences in athletic performance. Endocr Rev. 39(5):803\u2013829, 2018.","journal-title":"Endocr Rev."},{"issue":"1","key":"859_CR5","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.mayocp.2017.11.006","volume":"93","author":"A Elagizi","year":"2018","unstructured":"Elagizi, A., T. S. K\u00f6hler, and C. J. Lavie. Testosterone and cardiovascular health. Mayo Clin Proc. 93(1):83\u2013100, 2018.","journal-title":"Mayo Clin Proc."},{"issue":"11","key":"859_CR6","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1161\/01.RES.84.11.1285","volume":"84","author":"N Harada","year":"1999","unstructured":"Harada, N., H. Sasano, H. Murakami, T. Ohkuma, H. Nagura, and Y. Takagi. Localized expression of aromatase in human vascular tissues. Circ Res. 84(11):1285\u20131291, 1999.","journal-title":"Circ Res."},{"issue":"3","key":"859_CR7","doi-asserted-by":"publisher","first-page":"453","DOI":"10.5534\/wjmh.240029","volume":"43","author":"ALM Swislocki","year":"2025","unstructured":"Swislocki, A. L. M., and M. L. Eisenberg. A review on testosterone: estradiol ratio-does it matter, How do you measure it, and can you optimize it? World J Mens Health. 43(3):453\u2013464, 2025.","journal-title":"World J Mens Health."},{"key":"859_CR8","unstructured":"Antoniou-Tsigkos A, Zapanti E, Ghizzoni L, Mastorakos G. Adrenal Androgens: MDText.com; 2019."},{"key":"859_CR9","unstructured":"Handelsman DJ. Androgen Physiology, Pharmacology, Use and Misuse. In: Feingold KR, Anawalt B, Boyce A, Chrousos G, de Herder WW, Dhatariya K, et al., editors. Endotext: MDText.com, Inc.; 2020."},{"issue":"6","key":"859_CR10","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1097\/MED.0000000000000891","volume":"31","author":"JA Nyamaah","year":"2024","unstructured":"Nyamaah, J. A., N. Narinx, L. Antonio, and D. Vanderschueren. Use of calculated free testosterone in men: advantages and limitations. Curr Opin Endocrinol Diabetes Obes. 31(6):230\u2013235, 2024.","journal-title":"Curr Opin Endocrinol Diabetes Obes."},{"issue":"4","key":"859_CR11","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1016\/j.juro.2011.11.095","volume":"187","author":"BD Anawalt","year":"2012","unstructured":"Anawalt, B. D., J. M. Hotaling, T. J. Walsh, and A. M. Matsumoto. Performance of total testosterone measurement to predict free testosterone for the biochemical evaluation of male hypogonadism. J Urol. 187(4):1369\u20131373, 2012.","journal-title":"J Urol."},{"issue":"7","key":"859_CR12","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1172\/JCI0214060","volume":"109","author":"KN Hogeveen","year":"2002","unstructured":"Hogeveen, K. N., P. Cousin, M. Pugeat, D. Dewailly, B. Soudan, and G. L. Hammond. Human sex hormone-binding globulin variants associated with hyperandrogenism and ovarian dysfunction. J Clin Invest. 109(7):973\u2013981, 2002.","journal-title":"J Clin Invest."},{"issue":"3","key":"859_CR13","doi-asserted-by":"publisher","first-page":"R47","DOI":"10.1530\/JOE-12-0582","volume":"217","author":"DM Kelly","year":"2013","unstructured":"Kelly, D. M., and T. H. Jones. Testosterone: a vascular hormone in health and disease. J Endocrinol. 217(3):R47-71, 2013.","journal-title":"J Endocrinol."},{"issue":"4","key":"859_CR14","doi-asserted-by":"publisher","first-page":"H1210","DOI":"10.1152\/ajpheart.01210.2010","volume":"300","author":"J Cai","year":"2011","unstructured":"Cai, J., Y. Hong, C. Weng, C. Tan, J. Imperato-McGinley, and Y. S. Zhu. Androgen stimulates endothelial cell proliferation via an androgen receptor\/VEGF\/cyclin A-mediated mechanism. Am J Physiol Heart Circ Physiol. 300(4):H1210\u2013H1221, 2011.","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"859_CR15","doi-asserted-by":"publisher","first-page":"316","DOI":"10.3389\/fendo.2020.00316","volume":"11","author":"G Barrientos","year":"2020","unstructured":"Barrientos, G., P. Llanos, C. Basualto-Alarc\u00f3n, and M. Estrada. Androgen-regulated cardiac metabolism in aging men. Front Endocrinol. 11:316, 2020.","journal-title":"Front Endocrinol."},{"issue":"4","key":"859_CR16","doi-asserted-by":"publisher","first-page":"e000271","DOI":"10.1161\/JAHA.113.000271","volume":"2","author":"MJ Herring","year":"2013","unstructured":"Herring, M. J., P. M. Oskui, S. L. Hale, and R. A. Kloner. Testosterone and the cardiovascular system: a comprehensive review of the basic science literature. J Am Heart Assoc. 2(4):e000271, 2013.","journal-title":"J Am Heart Assoc."},{"key":"859_CR17","doi-asserted-by":"crossref","unstructured":"Monterio de Resende M, Huw LY, Qian HS, Kauser K. Role of endothelial nitric oxide in bone marrow-derived progenitor cell mobilization. Handbook of Experimental Pharmacology: Springer Berlin Heidelberg; 2007. p. 37-44.","DOI":"10.1007\/978-3-540-68976-8_2"},{"issue":"4","key":"859_CR18","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1210\/endrev\/bnab041","volume":"43","author":"F Mauvais-Jarvis","year":"2022","unstructured":"Mauvais-Jarvis, F., C. A. Lange, and E. R. Levin. Membrane-initiated estrogen, androgen, and progesterone receptor signaling in health and disease. Endocr Rev. 43(4):720\u2013742, 2022.","journal-title":"Endocr Rev."},{"issue":"821","key":"859_CR19","doi-asserted-by":"publisher","first-page":"eadi7861","DOI":"10.1126\/scisignal.adi7861","volume":"17","author":"H Kalyanaraman","year":"2024","unstructured":"Kalyanaraman, H., D. E. Casteel, S. P. China, S. Zhuang, G. R. Boss, and R. B. Pilz. A plasma membrane-associated form of the androgen receptor enhances nuclear androgen signaling in osteoblasts and prostate cancer cells. Sci Signal. 17(821):eadi7861, 2024.","journal-title":"Sci Signal."},{"issue":"2","key":"859_CR20","doi-asserted-by":"publisher","first-page":"R233","DOI":"10.1152\/ajpregu.00338.2003","volume":"286","author":"JM Orshal","year":"2004","unstructured":"Orshal, J. M., and R. A. Khalil. Gender, sex hormones, and vascular tone. Am J Physiol Regul Integr Comp Physiol. 286(2):R233\u2013R249, 2004.","journal-title":"Am J Physiol Regul Integr Comp Physiol."},{"issue":"3","key":"859_CR21","doi-asserted-by":"publisher","first-page":"e55","DOI":"10.1161\/ATVBAHA.119.313046","volume":"40","author":"JR Hu","year":"2020","unstructured":"Hu, J. R., M. S. Duncan, and A. K. Morgans. Cardiovascular effects of androgen deprivation therapy in prostate cancer: Contemporary meta-analyses. Arterioscler Thromb Vasc Biol. 40(3):e55\u2013e64, 2020.","journal-title":"Arterioscler Thromb Vasc Biol."},{"issue":"1","key":"859_CR22","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/PPO.0b013e318282635a","volume":"19","author":"D Rathkopf","year":"2013","unstructured":"Rathkopf, D., and H. I. Scher. Androgen receptor antagonists in castration-resistant prostate cancer. Cancer J. 19(1):43\u201349, 2013.","journal-title":"Cancer J."},{"issue":"1\u20132","key":"859_CR23","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jsbmb.2010.11.005","volume":"125","author":"TS Vasaitis","year":"2011","unstructured":"Vasaitis, T. S., R. D. Bruno, and V. C. O. Njar. CYP17 inhibitors for prostate cancer therapy. J Steroid Biochem Mol Biol. 125(1\u20132):23\u201331, 2011.","journal-title":"J Steroid Biochem Mol Biol."},{"issue":"10","key":"859_CR24","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/S1470-2045(09)70229-3","volume":"10","author":"Y Chen","year":"2009","unstructured":"Chen, Y., N. J. Clegg, and H. I. Scher. Anti-androgens and androgen-depleting therapies in prostate cancer: new agents for an established target. Lancet Oncol. 10(10):981\u2013991, 2009.","journal-title":"Lancet Oncol."},{"issue":"5","key":"859_CR25","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1177\/1074248417691136","volume":"22","author":"AM Traish","year":"2017","unstructured":"Traish, A. M., A. Haider, K. S. Haider, G. Doros, and F. Saad. Long-term testosterone therapy improves cardiometabolic function and reduces risk of cardiovascular disease in men with hypogonadism: A real-life observational registry study setting comparing treated and untreated (control) groups. J Cardiovasc Pharmacol Ther. 22(5):414\u2013433, 2017.","journal-title":"J Cardiovasc Pharmacol Ther."},{"issue":"6","key":"859_CR26","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/S2213-8587(16)00112-1","volume":"4","author":"CJD Wallis","year":"2016","unstructured":"Wallis, C. J. D., K. Lo, and Y. Lee. Survival and cardiovascular events in men treated with testosterone replacement therapy: an intention-to-treat observational cohort study. Lancet Diabetes Endocrinol. 4(6):498\u2013506, 2016.","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"2","key":"859_CR27","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.cct.2008.10.005","volume":"30","author":"NK LeBrasseur","year":"2009","unstructured":"LeBrasseur, N. K., N. Lajevardi, R. Miciek, N. Mazer, T. W. Storer, and S. Bhasin. Effects of testosterone therapy on muscle performance and physical function in older men with mobility limitations (The TOM Trial): design and methods. Contemp Clin Trials. 30(2):133\u2013140, 2009.","journal-title":"Contemp Clin Trials."},{"issue":"4","key":"859_CR28","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1001\/jamainternmed.2016.9546","volume":"177","author":"TC Cheetham","year":"2017","unstructured":"Cheetham, T. C., J. An, and S. J. Jacobsen. Association of testosterone replacement with cardiovascular outcomes among men with androgen deficiency. JAMA Intern Med. 177(4):491\u2013499, 2017.","journal-title":"JAMA Intern Med."},{"issue":"6","key":"859_CR29","doi-asserted-by":"publisher","first-page":"726","DOI":"10.2164\/jandrol.108.007005","volume":"30","author":"AE Heufelder","year":"2009","unstructured":"Heufelder, A. E., F. Saad, M. C. Bunck, and L. Gooren. Fifty-two-week treatment with diet and exercise plus transdermal testosterone reverses the metabolic syndrome and improves glycemic control in men with newly diagnosed type 2 diabetes and subnormal plasma testosterone. J Androl. 30(6):726\u2013733, 2009.","journal-title":"J Androl."},{"issue":"18","key":"859_CR30","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1056\/NEJMoa020265","volume":"347","author":"D Levy","year":"2002","unstructured":"Levy, D., S. Kenchaiah, and M. G. Larson. Long-term trends in the incidence of and survival with heart failure. N Engl J Med. 347(18):1397\u20131402, 2002.","journal-title":"N Engl J Med."},{"issue":"10","key":"859_CR31","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.jacc.2009.04.078","volume":"54","author":"G Caminiti","year":"2009","unstructured":"Caminiti, G., M. Volterrani, and F. Iellamo. Effect of long-acting testosterone treatment on functional exercise capacity, skeletal muscle performance, insulin resistance, and baroreflex sensitivity in elderly patients with chronic heart failure a double-blind, placebo-controlled, randomized study. J Am Coll Cardiol. 54(10):919\u2013927, 2009.","journal-title":"J Am Coll Cardiol."},{"key":"859_CR32","doi-asserted-by":"publisher","first-page":"392432","DOI":"10.1155\/2014\/392432","volume":"2014","author":"A Mirdamadi","year":"2014","unstructured":"Mirdamadi, A., M. Garakyaraghi, A. Pourmoghaddas, A. Bahmani, H. Mahmoudi, and M. Gharipour. Beneficial effects of testosterone therapy on functional capacity, cardiovascular parameters, and quality of life in patients with congestive heart failure. Biomed Res Int. 2014:392432, 2014.","journal-title":"Biomed Res Int."},{"issue":"16","key":"859_CR33","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1016\/j.jacc.2010.03.090","volume":"56","author":"F Iellamo","year":"2010","unstructured":"Iellamo, F., M. Volterrani, and G. Caminiti. Testosterone therapy in women with chronic heart failure: a pilot double-blind, randomized, placebo-controlled study. J Am Coll Cardiol. 56(16):1310\u20131316, 2010.","journal-title":"J Am Coll Cardiol."},{"issue":"1","key":"859_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0033-0620(98)80019-4","volume":"41","author":"ML Sullivan","year":"1998","unstructured":"Sullivan, M. L., C. M. Martinez, P. Gennis, and E. J. Gallagher. The cardiac toxicity of anabolic steroids. Prog Cardiovasc Dis. 41(1):1\u201315, 1998.","journal-title":"Prog Cardiovasc Dis."},{"issue":"1","key":"859_CR35","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.ijcard.2005.11.033","volume":"114","author":"M Di Paolo","year":"2007","unstructured":"Di Paolo, M., M. Agozzino, and C. Toni. Sudden anabolic steroid abuse-related death in athletes. Int J Cardiol. 114(1):114\u2013117, 2007.","journal-title":"Int J Cardiol."},{"issue":"2","key":"859_CR36","first-page":"172","volume":"86","author":"RD Dickerman","year":"1995","unstructured":"Dickerman, R. D., F. Schaller, I. Prather, and W. J. McConathy. Sudden cardiac death in a 20-year-old bodybuilder using anabolic steroids. Cardiology. 86(2):172\u2013173, 1995.","journal-title":"Cardiology."},{"key":"859_CR37","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ijcard.2021.12.009","volume":"348","author":"S Caselli","year":"2022","unstructured":"Caselli, S., M. Cicconetti, D. Niederseer, C. Schmied, C. Attenhofer Jost, and A. Pelliccia. Left ventricular hypertrophy in athletes, a case-control analysis of interindividual variability. Int J Cardiol. 348:157\u2013162, 2022.","journal-title":"Int J Cardiol."},{"issue":"2","key":"859_CR38","doi-asserted-by":"publisher","first-page":"80","DOI":"10.15420\/ecr.2017:12:1","volume":"12","author":"A Malhotra","year":"2017","unstructured":"Malhotra, A., and S. Sharma. Hypertrophic cardiomyopathy in athletes. Eur Cardiol. 12(2):80\u201382, 2017.","journal-title":"Eur Cardiol."},{"issue":"5","key":"859_CR39","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.jacc.2013.03.062","volume":"62","author":"I Olivotto","year":"2013","unstructured":"Olivotto, I., B. J. Maron, B. Tomberli, E. Appelbaum, C. Salton, T. S. Haas, C. M. Gibson, S. Nistri, E. Servettini, R. H. Chan, J. E. Udelson, J. R. Lesser, F. Cecchi, W. J. Manning, and M. S. Maron. Obesity and its association to phenotype and clinical course in hypertrophic cardiomyopathy. J Am Coll Cardiol. 62(5):449\u2013457, 2013.","journal-title":"J Am Coll Cardiol."},{"issue":"5","key":"859_CR40","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1136\/hrt.2003.015719","volume":"90","author":"A Urhausen","year":"2004","unstructured":"Urhausen, A., T. Albers, and W. Kindermann. Are the cardiac effects of anabolic steroid abuse in strength athletes reversible? Heart. 90(5):496\u2013501, 2004.","journal-title":"Heart."},{"key":"859_CR41","unstructured":"Surveillance Research Program NCI. SEER*Explorer: An interactive website for SEER cancer statistics. 2026."},{"key":"859_CR42","doi-asserted-by":"publisher","first-page":"103061","DOI":"10.1016\/j.eclinm.2024.103061","volume":"80","author":"A Morgentaler","year":"2025","unstructured":"Morgentaler, A. O\u2019 testosterone, where is thy sting? A Urologist\u2019s reflection on testosterone and prostate cancer. EClinicalMedicine. 80:103061, 2025.","journal-title":"EClinicalMedicine."},{"issue":"10","key":"859_CR43","doi-asserted-by":"publisher","first-page":"728.e13","DOI":"10.1016\/j.urolonc.2021.01.030","volume":"39","author":"A Csizmarik","year":"2021","unstructured":"Csizmarik, A., B. Hadaschik, G. Kramer, P. Nyirady, and T. Szarvas. Mechanisms and markers of resistance to androgen signaling inhibitors in patients with metastatic castration-resistant prostate cancer. Urol Oncol. 39(10):728.e13-e24, 2021.","journal-title":"Urol Oncol."},{"issue":"12","key":"859_CR44","doi-asserted-by":"publisher","first-page":"e2348692","DOI":"10.1001\/jamanetworkopen.2023.48692","volume":"6","author":"S Bhasin","year":"2023","unstructured":"Bhasin, S., T. G. Travison, K. M. Pencina, M. O\u2019Leary, G. R. Cunningham, A. M. Lincoff, S. E. Nissen, M. S. Lucia, M. A. Preston, M. Khera, N. Khan, M. C. Snabes, X. Li, C. M. Tangen, K. A. Buhr, et al. Prostate safety events during testosterone replacement therapy in men with hypogonadism: A randomized clinical trial. JAMA Netw Open. 6(12):e2348692, 2023.","journal-title":"JAMA Netw Open."},{"issue":"2","key":"859_CR45","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.eururo.2008.09.024","volume":"55","author":"A Morgentaler","year":"2009","unstructured":"Morgentaler, A., and A. M. Traish. Shifting the paradigm of testosterone and prostate cancer: the saturation model and the limits of androgen-dependent growth. Eur Urol. 55(2):310\u2013320, 2009.","journal-title":"Eur Urol."},{"issue":"27","key":"859_CR46","doi-asserted-by":"publisher","first-page":"4448","DOI":"10.1200\/JCO.2006.06.2497","volume":"24","author":"NL Keating","year":"2006","unstructured":"Keating, N. L., A. J. O\u2019Malley, and M. R. Smith. Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer. J Clin Oncol. 24(27):4448\u20134456, 2006.","journal-title":"J Clin Oncol."},{"issue":"1","key":"859_CR47","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s12885-016-2221-5","volume":"16","author":"F Meng","year":"2016","unstructured":"Meng, F., S. Zhu, and J. Zhao. Stroke related to androgen deprivation therapy for prostate cancer: a meta-analysis and systematic review. BMC Cancer. 16(1):180, 2016.","journal-title":"BMC Cancer."},{"issue":"9","key":"859_CR48","doi-asserted-by":"publisher","first-page":"e107516","DOI":"10.1371\/journal.pone.0107516","volume":"9","author":"J Zhao","year":"2014","unstructured":"Zhao, J., S. Zhu, and L. Sun. Androgen deprivation therapy for prostate cancer is associated with cardiovascular morbidity and mortality: a meta-analysis of population-based observational studies. PLoS One. 9(9):e107516, 2014.","journal-title":"PLoS One."},{"issue":"3","key":"859_CR49","doi-asserted-by":"publisher","first-page":"e645","DOI":"10.1016\/j.clgc.2017.12.007","volume":"16","author":"R Iacovelli","year":"2018","unstructured":"Iacovelli, R., C. Ciccarese, and E. Bria. The cardiovascular toxicity of abiraterone and enzalutamide in prostate cancer. Clin Genitourin Cancer. 16(3):e645\u2013e653, 2018.","journal-title":"Clin Genitourin Cancer."},{"issue":"48","key":"859_CR50","doi-asserted-by":"publisher","first-page":"84572","DOI":"10.18632\/oncotarget.20028","volume":"8","author":"RB Moreira","year":"2017","unstructured":"Moreira, R. B., M. Debiasi, and E. Francini. Differential side effects profile in patients with mCRPC treated with abiraterone or enzalutamide: a meta-analysis of randomized controlled trials. Oncotarget. 8(48):84572\u201384578, 2017.","journal-title":"Oncotarget."},{"issue":"8","key":"859_CR51","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.steroids.2013.04.009","volume":"78","author":"A Dokras","year":"2013","unstructured":"Dokras, A. Cardiovascular disease risk in women with PCOS. Steroids. 78(8):773\u2013776, 2013.","journal-title":"Steroids."},{"issue":"5","key":"859_CR52","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1210\/jc.2009-2724","volume":"95","author":"RA Wild","year":"2010","unstructured":"Wild, R. A., E. Carmina, and E. Diamanti-Kandarakis. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the androgen excess and polycystic ovary syndrome (AE-PCOS) society. J Clin Endocrinol Metab. 95(5):2038\u20132049, 2010.","journal-title":"J Clin Endocrinol Metab."},{"key":"859_CR53","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2147\/IJWH.S11304","volume":"3","author":"A Badawy","year":"2011","unstructured":"Badawy, A., and A. Elnashar. Treatment options for polycystic ovary syndrome. Int J Womens Health. 3:25\u201335, 2011.","journal-title":"Int J Womens Health."},{"issue":"15","key":"859_CR54","doi-asserted-by":"publisher","first-page":"4743","DOI":"10.1073\/pnas.1418216112","volume":"112","author":"F Wang","year":"2015","unstructured":"Wang, F., J. Pan, and Y. Liu. Alternative splicing of the androgen receptor in polycystic ovary syndrome. Proc Natl Acad Sci U S A. 112(15):4743\u20134748, 2015.","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"1","key":"859_CR55","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1530\/JOE-15-0518","volume":"229","author":"CK Huang","year":"2016","unstructured":"Huang, C. K., S. O. Lee, E. Chang, H. Pang, and C. Chang. Androgen receptor (AR) in cardiovascular diseases. J Endocrinol. 229(1):R1\u2013R16, 2016.","journal-title":"J Endocrinol."},{"issue":"1","key":"859_CR56","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1210\/jc.2007-1792","volume":"93","author":"GA Laughlin","year":"2008","unstructured":"Laughlin, G. A., E. Barrett-Connor, and J. Bergstrom. Low serum testosterone and mortality in older men. J Clin Endocrinol Metab. 93(1):68\u201375, 2008.","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"859_CR57","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1161\/01.CIR.98.3.256","volume":"98","author":"JD Marsh","year":"1998","unstructured":"Marsh, J. D., M. H. Lehmann, R. H. Ritchie, J. K. Gwathmey, G. E. Green, and R. J. Schiebinger. Androgen receptors mediate hypertrophy in cardiac myocytes. Circulation. 98(3):256\u2013261, 1998.","journal-title":"Circulation."},{"issue":"1","key":"859_CR58","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s12265-019-09907-z","volume":"13","author":"J Wu","year":"2020","unstructured":"Wu, J., F. Dai, C. Li, and Y. Zou. Gender differences in cardiac hypertrophy. J Cardiovasc Transl Res. 13(1):73\u201384, 2020.","journal-title":"J Cardiovasc Transl Res."},{"issue":"12","key":"859_CR59","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1096\/fj.02-0138com","volume":"16","author":"T Thum","year":"2002","unstructured":"Thum, T., and J. Borlak. Testosterone, cytochrome P450, and cardiac hypertrophy. FASEB J. 16(12):1537\u20131549, 2002.","journal-title":"FASEB J."},{"issue":"7","key":"859_CR60","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1136\/hrt.2009.181065","volume":"96","author":"G G\u00fcder","year":"2010","unstructured":"G\u00fcder, G., S. Frantz, and J. Bauersachs. Low circulating androgens and mortality risk in heart failure. Heart. 96(7):504\u2013509, 2010.","journal-title":"Heart."},{"issue":"10","key":"859_CR61","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1016\/S0002-9149(03)00266-2","volume":"91","author":"BJ Maron","year":"2003","unstructured":"Maron, B. J., S. A. Casey, D. G. Hurrell, and D. M. Aeppli. Relation of left ventricular thickness to age and gender in hypertrophic cardiomyopathy. Am J Cardiol. 91(10):1195\u20131198, 2003.","journal-title":"Am J Cardiol."},{"issue":"6","key":"859_CR62","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.amjcard.2011.05.016","volume":"108","author":"FJ Pastor-P\u00e9rez","year":"2011","unstructured":"Pastor-P\u00e9rez, F. J., S. Manzano-Fern\u00e1ndez, and I. P. Garrido Bravo. Anabolic status and functional impairment in men with mild chronic heart failure. Am J Cardiol. 108(6):862\u2013866, 2011.","journal-title":"Am J Cardiol."},{"issue":"10","key":"859_CR63","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/S0195-668X(03)00083-6","volume":"24","author":"PJ Pugh","year":"2003","unstructured":"Pugh, P. J., T. H. Jones, and K. S. Channer. Acute haemodynamic effects of testosterone in men with chronic heart failure. Eur Heart J. 24(10):909\u2013915, 2003.","journal-title":"Eur Heart J."},{"issue":"7","key":"859_CR64","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1111\/j.1464-410X.2011.10459.x","volume":"109","author":"SD Chung","year":"2012","unstructured":"Chung, S. D., Y. K. Chen, F. J. Wu, and H. C. Lin. Hormone therapy for prostate cancer and the risk of stroke: a 5-year follow-up study. BJU Int. 109(7):1001\u20131005, 2012.","journal-title":"BJU Int."},{"issue":"4","key":"859_CR65","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1042\/CS20050354","volume":"111","author":"CJ Malkin","year":"2006","unstructured":"Malkin, C. J., R. D. Jones, T. H. Jones, and K. S. Channer. Effect of testosterone on ex vivo vascular reactivity in man. Clin Sci. 111(4):265\u2013274, 2006.","journal-title":"Clin Sci."},{"key":"859_CR66","unstructured":"Shaw PM, Loree J, Gibbons RC. Abdominal Aortic Aneurysm: StatPearls Publishing; 2023."},{"issue":"3","key":"859_CR67","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1530\/JOE-18-0646","volume":"241","author":"BK Son","year":"2019","unstructured":"Son, B. K., T. Kojima, S. Ogawa, and M. Akishita. Testosterone inhibits aneurysm formation and vascular inflammation in male mice. J Endocrinol. 241(3):307\u2013317, 2019.","journal-title":"J Endocrinol."},{"key":"859_CR68","doi-asserted-by":"publisher","first-page":"609161","DOI":"10.3389\/fimmu.2020.609161","volume":"11","author":"Z Yuan","year":"2020","unstructured":"Yuan, Z., Y. Lu, J. Wei, J. Wu, J. Yang, and Z. Cai. Abdominal aortic aneurysm: Roles of inflammatory cells. Front Immunol. 11:609161, 2020.","journal-title":"Front Immunol."},{"issue":"4","key":"859_CR69","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1161\/HYPERTENSIONAHA.115.05654","volume":"66","author":"CK Huang","year":"2015","unstructured":"Huang, C. K., J. Luo, and K. P. Lai. Androgen receptor promotes abdominal aortic aneurysm development via modulating inflammatory interleukin-1\u03b1 and transforming growth factor-\u03b21 expression. Hypertension. 66(4):881\u2013891, 2015.","journal-title":"Hypertension."},{"issue":"9","key":"859_CR70","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1161\/hc0902.104353","volume":"105","author":"P Libby","year":"2002","unstructured":"Libby, P., P. M. Ridker, and A. Maseri. Inflammation and atherosclerosis. Circulation. 105(9):1135\u20131143, 2002.","journal-title":"Circulation."},{"issue":"12","key":"859_CR71","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1016\/j.amjcard.2011.02.318","volume":"107","author":"C Sinning","year":"2011","unstructured":"Sinning, C., P. S. Wild, and F. M. O. Echevarria. Sex differences in early carotid atherosclerosis (from the community-based Gutenberg-Heart Study). Am J Cardiol. 107(12):1841\u20131847, 2011.","journal-title":"Am J Cardiol."},{"issue":"6","key":"859_CR72","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1161\/HYPERTENSIONAHA.113.02804","volume":"63","author":"CK Huang","year":"2014","unstructured":"Huang, C. K., H. Pang, and L. Wang. New therapy via targeting androgen receptor in monocytes\/macrophages to battle atherosclerosis. Hypertension. 63(6):1345\u20131353, 2014.","journal-title":"Hypertension."},{"issue":"3","key":"859_CR73","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3109\/08982104.2013.863208","volume":"24","author":"S Zhaorigetu","year":"2014","unstructured":"Zhaorigetu, S., C. Rodriguez-Aguayo, A. K. Sood, G. Lopez-Berestein, and B. L. Walton. Delivery of negatively charged liposomes into the atherosclerotic plaque of apolipoprotein E-deficient mouse aortic tissue. J Liposome Res. 24(3):182\u2013190, 2014.","journal-title":"J Liposome Res."},{"issue":"2","key":"859_CR74","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1161\/01.STR.32.2.454","volume":"32","author":"NM van Popele","year":"2001","unstructured":"van Popele, N. M., D. E. Grobbee, and M. L. Bots. Association between arterial stiffness and atherosclerosis. Stroke. 32(2):454\u2013460, 2001.","journal-title":"Stroke."},{"issue":"7","key":"859_CR75","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1001\/jama.2016.21043","volume":"317","author":"MJ Budoff","year":"2017","unstructured":"Budoff, M. J., S. S. Ellenberg, and C. E. Lewis. Testosterone treatment and coronary artery plaque volume in older men with low testosterone. JAMA. 317(7):708\u2013716, 2017.","journal-title":"JAMA."},{"issue":"6","key":"859_CR76","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s10654-009-9322-2","volume":"24","author":"T Vikan","year":"2009","unstructured":"Vikan, T., S. H. Johnsen, H. Schirmer, I. Nj\u00f8lstad, and J. Svartberg. Endogenous testosterone and the prospective association with carotid atherosclerosis in men: the Troms\u00f8 study. Eur J Epidemiol. 24(6):289\u2013295, 2009.","journal-title":"Eur J Epidemiol."},{"issue":"7","key":"859_CR77","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1161\/01.RES.84.7.813","volume":"84","author":"P Alexandersen","year":"1999","unstructured":"Alexandersen, P., J. Haarbo, I. Byrjalsen, H. Lawaetz, and C. Christiansen. Natural androgens inhibit male atherosclerosis: a study in castrated, cholesterol-fed rabbits. Circ Res. 84(7):813\u2013819, 1999.","journal-title":"Circ Res."},{"issue":"11","key":"859_CR78","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1161\/ATVBAHA.114.302523","volume":"34","author":"KE Yutzey","year":"2014","unstructured":"Yutzey, K. E., L. L. Demer, and S. C. Body. Calcific aortic valve disease: a consensus summary from the alliance of investigators on calcific aortic valve disease. Arterioscler Thromb Vasc Biol. 34(11):2387\u20132393, 2014.","journal-title":"Arterioscler Thromb Vasc Biol."},{"issue":"2","key":"859_CR79","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1080\/24748706.2017.1420273","volume":"2","author":"M Hervault","year":"2018","unstructured":"Hervault, M., and M. A. Clavel. Sex-related differences in calcific aortic valve stenosis: Pathophysiology, epidemiology, etiology, diagnosis, presentation, and outcomes. Struct Heart. 2(2):102\u2013113, 2018.","journal-title":"Struct Heart."},{"issue":"4","key":"859_CR80","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1161\/CIRCRESAHA.117.310440","volume":"120","author":"AM Porras","year":"2017","unstructured":"Porras, A. M., C. M. McCoy, and K. S. Masters. Calcific aortic valve disease: A battle of the sexes. Circ Res. 120(4):604\u2013606, 2017.","journal-title":"Circ Res."},{"issue":"7","key":"859_CR81","doi-asserted-by":"publisher","first-page":"e39980","DOI":"10.1371\/journal.pone.0039980","volume":"7","author":"CM McCoy","year":"2012","unstructured":"McCoy, C. M., D. Q. Nicholas, and K. S. Masters. Sex-related differences in gene expression by porcine aortic valvular interstitial cells. PLoS One. 7(7):e39980, 2012.","journal-title":"PLoS One."},{"issue":"3","key":"859_CR82","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1152\/physiol.00025.2016","volume":"32","author":"Y Sritharen","year":"2017","unstructured":"Sritharen, Y., M. Enriquez-Sarano, H. V. Schaff, G. Casaclang-Verzosa, and J. D. Miller. Pathophysiology of aortic valve stenosis: Is it both fibrocalcific and sex specific? Physiology. 32(3):182\u2013196, 2017.","journal-title":"Physiology."},{"issue":"21","key":"859_CR83","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1093\/eurheartj\/eht547","volume":"36","author":"N Latif","year":"2015","unstructured":"Latif, N., P. Sarathchandra, A. H. Chester, and M. H. Yacoub. Expression of smooth muscle cell markers and co-activators in calcified aortic valves. Eur Heart J. 36(21):1335\u20131345, 2015.","journal-title":"Eur Heart J."},{"issue":"1","key":"859_CR84","doi-asserted-by":"publisher","first-page":"24807","DOI":"10.1038\/srep24807","volume":"6","author":"D Zhu","year":"2016","unstructured":"Zhu, D., P. W. F. Hadoke, and J. Wu. Ablation of the androgen receptor from vascular smooth muscle cells demonstrates a role for testosterone in vascular calcification. Sci Rep. 6(1):24807, 2016.","journal-title":"Sci Rep."},{"issue":"6","key":"859_CR85","doi-asserted-by":"publisher","first-page":"e13125","DOI":"10.14814\/phy2.13125","volume":"5","author":"ARM Khalifa","year":"2017","unstructured":"Khalifa, A. R. M., E. A. Abdel-Rahman, and A. M. Mahmoud. Sex-specific differences in mitochondria biogenesis, morphology, respiratory function, and ROS homeostasis in young mouse heart and brain. Physiol Rep. 5(6):e13125, 2017.","journal-title":"Physiol Rep."},{"issue":"4","key":"859_CR86","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/s41578-021-00381-1","volume":"7","author":"R Lock","year":"2022","unstructured":"Lock, R., H. Al Asafen, and S. Fleischer. A framework for developing sex-specific engineered heart models. Nat Rev Mater. 7(4):295\u2013313, 2022.","journal-title":"Nat Rev Mater."},{"issue":"5","key":"859_CR87","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1161\/CIRCRESAHA.119.315491","volume":"125","author":"H Zhang","year":"2019","unstructured":"Zhang, H., L. Tian, and M. Shen. Generation of quiescent cardiac fibroblasts from human induced pluripotent stem cells for in vitro modeling of cardiac fibrosis. Circ Res. 125(5):552\u2013556, 2019.","journal-title":"Circ Res."},{"issue":"6","key":"859_CR88","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s00424-012-1193-9","volume":"465","author":"Y Zhu","year":"2013","unstructured":"Zhu, Y., X. Ai, R. A. Oster, D. M. Bers, and S. M. Pogwizd. Sex differences in repolarization and slow delayed rectifier potassium current and their regulation by sympathetic stimulation in rabbits. Pflugers Arch. 465(6):805\u2013818, 2013.","journal-title":"Pflugers Arch."},{"key":"859_CR89","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.actbio.2018.02.007","volume":"70","author":"Z Wang","year":"2018","unstructured":"Wang, Z., S. J. Lee, H. J. Cheng, J. J. Yoo, and A. Atala. 3D bioprinted functional and contractile cardiac tissue constructs. Acta Biomater. 70:48\u201356, 2018.","journal-title":"Acta Biomater."},{"issue":"15\u201316","key":"859_CR90","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1089\/ten.tea.2016.0027","volume":"22","author":"AH Fong","year":"2016","unstructured":"Fong, A. H., M. Romero-L\u00f3pez, and C. M. Heylman. Three-dimensional adult cardiac extracellular matrix promotes maturation of human induced pluripotent stem cell-derived cardiomyocytes. Tissue Eng Part A. 22(15\u201316):1016\u20131025, 2016.","journal-title":"Tissue Eng Part A."},{"issue":"424","key":"859_CR91","doi-asserted-by":"publisher","first-page":"eaam8645","DOI":"10.1126\/scitranslmed.aam8645","volume":"10","author":"BA Aguado","year":"2018","unstructured":"Aguado, B. A., J. C. Grim, A. M. Rosales, J. J. Watson-Capps, and K. S. Anseth. Engineering precision biomaterials for personalized medicine. Sci Transl Med. 10(424):eaam8645, 2018.","journal-title":"Sci Transl Med."},{"issue":"2","key":"859_CR92","doi-asserted-by":"publisher","first-page":"024112","DOI":"10.1088\/1758-5082\/6\/2\/024112","volume":"6","author":"P Kim","year":"2014","unstructured":"Kim, P., A. Yuan, K. H. Nam, A. Jiao, and D. H. Kim. Fabrication of poly(ethylene glycol): gelatin methacrylate composite nanostructures with tunable stiffness and degradation for vascular tissue engineering. Biofabrication. 6(2):024112, 2014.","journal-title":"Biofabrication."},{"key":"859_CR93","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.actbio.2019.07.046","volume":"97","author":"MN Monroe","year":"2019","unstructured":"Monroe, M. N., R. C. Nikonowicz, and K. J. Grande-Allen. Heterogeneous multi-laminar tissue constructs as a platform to evaluate aortic valve matrix-dependent pathogenicity. Acta Biomater. 97:420\u2013430, 2019.","journal-title":"Acta Biomater."},{"key":"859_CR94","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.mce.2017.02.005","volume":"446","author":"P Liu","year":"2017","unstructured":"Liu, P., X. Li, F. Song, P. Li, J. Wei, Q. Yan, X. Xu, J. Yang, C. Li, and X. Fu. Testosterone promotes tube formation of endothelial cells isolated from veins via activation of Smad1 protein. Mol Cell Endocrinol. 446:21\u201331, 2017.","journal-title":"Mol Cell Endocrinol."},{"issue":"6","key":"859_CR95","doi-asserted-by":"publisher","first-page":"4055","DOI":"10.1073\/pnas.052703199","volume":"99","author":"TK Mukherjee","year":"2002","unstructured":"Mukherjee, T. K., H. Dinh, G. Chaudhuri, and L. Nathan. Testosterone attenuates expression of vascular cell adhesion molecule-1 by conversion to estradiol by aromatase in endothelial cells: implications in atherosclerosis. Proc Natl Acad Sci U S A. 99(6):4055\u20134060, 2002.","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"4","key":"859_CR96","doi-asserted-by":"publisher","first-page":"614","DOI":"10.3892\/br.2013.107","volume":"1","author":"T Otsuka","year":"2013","unstructured":"Otsuka, T., A. Hamada, K. Iguchi, S. Usui, and K. Hirano. Suppression of metallothionein 3 gene expression by androgen in LNCaP prostate cancer cells. Biomed Rep. 1(4):614\u2013618, 2013.","journal-title":"Biomed Rep."},{"issue":"9","key":"859_CR97","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1158\/1541-7786.MCR-10-0008","volume":"8","author":"Y Sekine","year":"2010","unstructured":"Sekine, Y., S. J. Demosky, J. A. Stonik, Y. Furuya, H. Koike, K. Suzuki, and A. T. Remaley. High-density lipoprotein induces proliferation and migration of human prostate androgen-independent cancer cells by an ABCA1-dependent mechanism. Mol Cancer Res. 8(9):1284\u20131294, 2010.","journal-title":"Mol Cancer Res."},{"issue":"8","key":"859_CR98","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1073\/pnas.83.8.2496","volume":"83","author":"Y Berthois","year":"1986","unstructured":"Berthois, Y., J. A. Katzenellenbogen, and B. S. Katzenellenbogen. Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture. Proc Natl Acad Sci U S A. 83(8):2496\u20132500, 1986.","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"3","key":"859_CR99","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/0303-7207(88)90072-X","volume":"57","author":"WV Welshons","year":"1988","unstructured":"Welshons, W. V., M. F. Wolf, C. S. Murphy, and V. C. Jordan. Estrogenic activity of phenol red. Mol Cell Endocrinol. 57(3):169\u2013178, 1988.","journal-title":"Mol Cell Endocrinol."},{"issue":"19","key":"859_CR100","doi-asserted-by":"publisher","first-page":"eadn3510","DOI":"10.1126\/sciadv.adn3510","volume":"10","author":"AK McClain","year":"2024","unstructured":"McClain, A. K., P. P. Monteleone, and J. Zoldan. Sex in cardiovascular disease: Why this biological variable should be considered in in vitro models. Sci Adv. 10(19):eadn3510, 2024.","journal-title":"Sci Adv."},{"issue":"11","key":"859_CR101","doi-asserted-by":"publisher","first-page":"H1485","DOI":"10.1152\/ajpheart.00809.2013","volume":"306","author":"RA Lopes","year":"2014","unstructured":"Lopes, R. A., K. B. Neves, C. R. Pestana, A. L. Queiroz, C. Z. Zanotto, A. Z. Chignalia, Y. M. Valim, L. R. Silveira, C. Curti, and R. C. Tostes. Testosterone induces apoptosis in vascular smooth muscle cells via extrinsic apoptotic pathway with mitochondria-generated reactive oxygen species involvement. Am J Physiol Heart Circ Physiol. 306(11):H1485\u2013H1494, 2014.","journal-title":"Am J Physiol Heart Circ Physiol."},{"issue":"2","key":"859_CR102","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1084\/jem.20091924","volume":"207","author":"DP Sieveking","year":"2010","unstructured":"Sieveking, D. P., P. Lim, R. W. Chow, L. L. Dunn, S. Bao, K. C. McGrath, A. K. Heather, D. J. Handelsman, D. S. Celermajer, and M. K. Ng. A sex-specific role for androgens in angiogenesis. J Exp Med. 207(2):345\u2013352, 2010.","journal-title":"J Exp Med."},{"issue":"9","key":"859_CR103","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s40618-014-0118-1","volume":"37","author":"G Annibalini","year":"2014","unstructured":"Annibalini, G., D. Agostini, C. Calcabrini, C. Martinelli, E. Colombo, M. Guescini, P. Tibollo, V. Stocchi, and P. Sestili. Effects of sex hormones on inflammatory response in male and female vascular endothelial cells. J Endocrinol Invest. 37(9):861\u2013869, 2014.","journal-title":"J Endocrinol Invest."},{"issue":"1","key":"859_CR104","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1161\/CIRCULATIONAHA.113.001533","volume":"128","author":"S Yoshida","year":"2013","unstructured":"Yoshida, S., K. Aihara, Y. Ikeda, Y. Sumitomo-Ueda, R. Uemoto, K. Ishikawa, T. Ise, S. Yagi, T. Iwase, Y. Mouri, M. Sakari, T. Matsumoto, K. Takeyama, M. Akaike, M. Matsumoto, et al. Androgen receptor promotes sex-independent angiogenesis in response to ischemia and is required for activation of vascular endothelial growth factor receptor signaling. Circulation. 128(1):60\u201371, 2013.","journal-title":"Circulation."},{"issue":"1","key":"859_CR105","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41413-019-0049-8","volume":"7","author":"N Bock","year":"2019","unstructured":"Bock, N., A. Shokoohmand, and T. Kryza. Engineering osteoblastic metastases to delineate the adaptive response of androgen-deprived prostate cancer in the bone metastatic microenvironment. Bone Res. 7(1):13, 2019.","journal-title":"Bone Res."},{"issue":"3","key":"859_CR106","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1210\/clinem\/dgz100","volume":"105","author":"T Wiwatpanit","year":"2020","unstructured":"Wiwatpanit, T., A. R. Murphy, and Z. Lu. Scaffold-free endometrial organoids respond to excess androgens associated with polycystic ovarian syndrome. J Clin Endocrinol Metab. 105(3):769\u2013780, 2020.","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"859_CR107","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jconrel.2009.09.013","volume":"141","author":"F Jordan","year":"2010","unstructured":"Jordan, F., A. Naylor, and C. A. Kelly. Sustained release hGH microsphere formulation produced by a novel supercritical fluid technology: in vivo studies. J Control Release. 141(2):153\u2013160, 2010.","journal-title":"J Control Release."},{"key":"859_CR108","doi-asserted-by":"crossref","unstructured":"Sacchetin PSC, Setti RF, Vieira e Rosa PdT, Moraes \u00c2. Properties of PLA\/PCL particles as vehicles for oral delivery of the androgen hormone 17\u03b1-methyltestosterone. Mater Sci Eng C Mater Biol Appl. 2016;58:870-81.","DOI":"10.1016\/j.msec.2015.09.071"},{"key":"859_CR109","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.addr.2018.04.018","volume":"139","author":"M Farina","year":"2019","unstructured":"Farina, M., J. F. Alexander, U. Thekkedath, M. Ferrari, and A. Grattoni. Cell encapsulation: Overcoming barriers in cell transplantation in diabetes and beyond. Adv Drug Deliv Rev. 139:92\u2013115, 2019.","journal-title":"Adv Drug Deliv Rev."},{"key":"859_CR110","doi-asserted-by":"crossref","unstructured":"Dang M, Koh AJ, Danciu T, McCauley LK, Ma PX. Preprogrammed long-term systemic pulsatile delivery of parathyroid hormone to strengthen bone. Adv Healthc Mater. 2017;6(3).","DOI":"10.1002\/adhm.201600901"},{"issue":"14","key":"859_CR111","doi-asserted-by":"publisher","first-page":"4695","DOI":"10.1113\/JP273142","volume":"595","author":"PC Yang","year":"2017","unstructured":"Yang, P. C., L. L. Perissinotti, and F. L\u00f3pez-Redondo. A multiscale computational modelling approach predicts mechanisms of female sex risk in the setting of arousal-induced arrhythmias. J Physiol. 595(14):4695\u20134723, 2017.","journal-title":"J Physiol."}],"container-title":["Cardiovascular Engineering and Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13239-026-00859-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13239-026-00859-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13239-026-00859-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T04:17:44Z","timestamp":1789705064000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13239-026-00859-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,17]]},"references-count":111,"alternative-id":["859"],"URL":"https:\/\/doi.org\/10.1007\/s13239-026-00859-5","relation":{},"ISSN":["1869-408X","1869-4098"],"issn-type":[{"value":"1869-408X","type":"print"},{"value":"1869-4098","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,17]]},"assertion":[{"value":"11 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors have no competing financial or non-financial interests to declare that are relevant to the content of this article.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethical Approval and Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have provided consent to publish this article.","order":3,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}}]}}